Itron (ITRI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
17 Feb, 2026Executive summary
Q4 2025 revenue was $572 million, down year-over-year due to portfolio changes and project timing; full-year revenue was $2.37–$2.4 billion, down 3%.
Adjusted EBITDA for Q4 was $99 million, up 21% year-over-year; full-year adjusted EBITDA was $374 million, up 16%.
Outcomes segment delivered record Q4 revenue, up 23%, supporting overall profitability.
Strategic acquisitions of Urbint and Locusview closed, launching the Resiliency Solutions segment.
Free cash flow for Q4 was $112 million, up $41 million; full-year free cash flow was $383 million, up $175 million.
Financial highlights
Q4 GAAP net income was $101.6–$102 million, up 75% year-over-year; full-year GAAP net income was $301 million, up 26%.
Q4 non-GAAP diluted EPS was $2.46, up $1.11; full-year non-GAAP diluted EPS was $7.13, up $1.51.
Q4 adjusted gross margin was 40.5–40.7%, up over 560 bps year-over-year.
Q4 free cash flow was $112 million; full-year free cash flow was $383 million.
Net cash from operating activities for the year was $406 million, up from $238 million.
Outlook and guidance
2026 revenue expected between $2.35–$2.45 billion, representing 1% growth at midpoint.
2026 non-GAAP EPS guidance is $5.75–$6.25 per share, with a 22% effective tax rate and lower interest income from acquisitions.
Q1 2026 revenue guidance is $565–$575 million, down 6% year-over-year; Q1 non-GAAP EPS expected at $1.20–$1.30.
Resiliency Solutions segment to contribute $65–$70 million in 2026 at ~70% gross margin, accretive to revenue and EBITDA but dilutive to EPS by $0.38, turning accretive by end of 2027.
ARR projected to grow mid-teens to 20% in 2026, including contributions from recent acquisitions.
Latest events from Itron
- Virtual annual meeting to vote on directors, executive pay, auditor, and ESG priorities.ITRI
Proxy filing23 Mar 2026 - Board recommends voting for all director nominees, say-on-pay, and auditor ratification.ITRI
Proxy filing23 Mar 2026 - Record 2025 earnings and cash flow, with new acquisitions fueling platform expansion.ITRI
Investor presentation17 Feb 2026 - Q2 revenue up 13% and full-year guidance raised on record segment results and margin gains.ITRI
Q2 20242 Feb 2026 - Q3 revenue up 10% and net income nearly doubled, prompting a raised full-year outlook.ITRI
Q3 202417 Jan 2026 - Record revenue, profit, and backlog set a strong foundation for continued growth in 2025.ITRI
Q4 202429 Dec 2025 - Net income up 27% with record margins, strong cash flow, and $4.7B backlog.ITRI
Q1 202523 Dec 2025 - 2025 proxy covers director election, say-on-pay, share increase, and strong 2024 results.ITRI
Proxy Filing1 Dec 2025 - Key votes include director election, pay, share increase, and ESG remains a top priority.ITRI
Proxy Filing1 Dec 2025